These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36105365)

  • 1. RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.
    Song T; Zhang H
    Breast J; 2022; 2022():4576789. PubMed ID: 36105365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
    Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
    Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
    Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.
    Dou JW; Shang RG; Lei XQ; Li KL; Guo ZZ; Ye K; Yang XJ; Li YW; Zhou YY; Yao J; Huang Q
    BMC Complement Altern Med; 2019 Nov; 19(1):304. PubMed ID: 31703679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting L1CAM Reverses Cisplatin Resistance of Triple Negative Breast Cancer Cells by Blocking AKT Signaling Pathway.
    Zhang LY; Shen ZX; Guo L
    Cancer Invest; 2022 Apr; 40(4):313-324. PubMed ID: 35040385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXL16 modulates the proliferation and autophagy in breast cancer cells via activating SRC-3-AKT signaling pathway.
    Yang M; Jing F
    Reprod Biol; 2021 Sep; 21(3):100538. PubMed ID: 34333223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
    Yi D; Xu L; Wang R; Lu X; Sang J
    Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
    Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
    Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling.
    Zhan CH; Ding DS; Zhang W; Wang HL; Mao ZY; Liu GJ
    Bioengineered; 2022 Apr; 13(4):8478-8489. PubMed ID: 35322748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
    Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.
    Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S
    Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinomenine inhibits hypoxia induced breast cancer side population cells metastasis by PI3K/Akt/mTOR pathway.
    Song L; Zhang H; Hu M; Liu C; Zhao Y; Zhang S; Liu D
    Bioorg Med Chem; 2021 Feb; 31():115986. PubMed ID: 33412412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.